Costanzi, Stefano
Dettaglio
Costanzi, Stefano
Pubblicazioni
Risultati 1 - 5 di 5 (tempo di esecuzione: 0.0 secondi).
Data di pubblicazione | Titolo | Autore(i) | File | |
---|---|---|---|---|
1 | 2015 | A SPRY2 mutation leading to MAPK/ERK pathway inhibition is associated with an autosomal dominant form of IgA nephropathy. | Sangiorgi, Eugenio; Gurrieri, Fiorella; Milillo, Annamaria; La Carpia, Francesca; Costanzi, Stefano; Martini, Maurizio; Larocca, Luigi Maria; Vischini, Gisella | - |
2 | 2009 | Combined treatment with renin-angiotensin system blockers and polyunsaturated fatty acids in proteinuric IgA nephropathy: A randomized controlled trial | Ferraro, Pietro Manuel; Ferraccioli, Gian Franco; Gambaro, Giovanni; Fulignati, Pierluigi; Costanzi, Stefano | - |
3 | 2018 | Contrast-enhanced ultrasonography in chronic glomerulonephritides: correlation with histological parameters of disease activity | Nestola, Manuela; De Matthaeis, Nicoletta; Ferraro, Pietro Manuel; Fuso, Paola; Costanzi, Stefano; Zannoni, Gian Franco; Pizzolante, Fabrizio; Vasquez Quadra, Sabina; Gambaro, Giovanni; Rapaccini, Gian Ludovico | - |
4 | 2018 | Defective activation of the MAPK/ERK pathway, leading to PARP1 and DNMT1 dysregulation, is a common defect in IgA nephropathy and Henoch-Schönlein purpura | Milillo, A; Molinario, C; Costanzi, S; Vischini, G; La Carpia, F; La Greca, F; Rigante, D; Gambaro, G; Gurrieri, F; Sangiorgi, E. | - |
5 | 2019 | Deterioration in Clinical Status Is Not Enough to Suspend Eculizumab: A Genetic Complement-Mediated Atypical Hemolytic Uremic Syndrome Case Report | Calvaruso, Luca; Naticchia, Alessandro; Ferraro, Pietro Manuel; Vischini, Gisella; Costanzi, Stefano | - |